C78.7

C78.7: Secondary malignant neoplasm of liver and intrahepatic bile duct

Billable / specific codeICD-10-CM

C78.7 is a billable, specific ICD-10-CM code for secondary malignant neoplasm of liver and intrahepatic bile duct. It is valid for submission on a claim.

Check C78.7 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above C78.7

A category’s note binds every code beneath it.

Written on C78: Secondary malignant neoplasm of respiratory and digestive organs

secondary carcinoid tumors of liver (C7B.02)
secondary carcinoid tumors of peritoneum (C7B.04)

Excludes2 inherited from the categories above C78.7

Not part of this code, but both may be coded when both are present.

Written on C78: Secondary malignant neoplasm of respiratory and digestive organs

lymph node metastases (C77.0)

Other codes that can never be billed with C78.7

Their own Excludes1 notes name this code, so the conflict is not listed above.

C22Malignant neoplasm of liver and intrahepatic bile ducts

Risk adjustment

C78.7 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 17 Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4.209 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C78.7 is named in 53 Medicare coverage policies: 53 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A52370Billing and Coding: Bevacizumab and biosimilars
A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article

Code history

Unchanged in every release from FY2024 to FY2027.